Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Biogen Inc. (BIIB)

Biogen To Acquire TJ Bio's Rights To Felzartamab In The Greater China Region 4/20/2026 7:41:06 AM

Biogen Secures Global Rights To Felzartamab With TJ Biopharma Deal In Greater China 4/20/2026 7:32:44 AM

Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS 4/3/2026 5:10:06 AM

Apellis Shares Surge 135% After Acquisition Agreement With Biogen 3/31/2026 10:41:56 AM

Biogen To Acquire Apellis 3/31/2026 7:21:54 AM

Biogen To Acquire Apellis For Approx. $5.6 Bln 3/31/2026 7:07:01 AM

Biogen Sayd FDA Grants Approval For High-Dose SPINRAZA Regimen For SMATreatment 3/30/2026 7:56:41 AM

Biogen Gets FDA Approval For High-Dose SPINRAZA Regimen For Spinal Muscular Atrophy Treatment 3/30/2026 7:34:43 AM

Biotech Stocks Facing FDA Decision In April 2026 3/30/2026 6:14:27 AM

Biogen's Litifilimab Shows Promise In Cutaneous Lupus Study 3/29/2026 9:56:05 PM

Biotech Stocks Facing FDA Decision In April 2026 3/26/2026 9:45:32 PM

Alteogen Stock Up On Upto $579 Mln Deal With Biogen For Hybrozyme-Based Subcutaneous Biologics 3/26/2026 9:05:00 AM

Biogen Presents Phase 1b Results Of Salanersen In SMA Patients; Phase 3 Trials Begin 3/11/2026 8:20:14 AM

Stoke: Data From Zorevunersen Studies Support Ongoing Global Phase 3 EMPEROR Study 3/5/2026 12:51:29 AM

Stoke Therapeutics And Biogen Announce First Evidence Of Disease Modification In Dravet Syndrome 3/4/2026 9:02:02 PM

Eisai And Biogen's Subcutaneous LEQEMBI Gets China NMPA's Priority Review In Early Alzheimer 2/9/2026 2:43:59 AM

Eisai And Biogen: Subcutaneous LEQEMBI For Early Alzheimer's Granted Priority Review By China's NMPA 2/8/2026 9:19:38 PM

BIIB Shares Jump 5% After Biogen Reports Q4 & Full-Year 2025 Results, 2026 Guidance 2/6/2026 12:30:40 PM

Biogen Q4 Results Top Estimates; Guides FY26 Adj. EPS Above Estimates 2/6/2026 6:45:37 AM

Biogen Q4 GAAP Loss Per Share $0.33; Non-GAAP EPS $1.99 2/6/2026 6:20:27 AM

- 1
- 2
- Next »

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap